logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
LGVN
Longeveron Inc.
6.90
2 x 5.22
2 x 8.66
bid
ask
+
0.18
2.68%
2 @ 07:30 PM
6.62 -0.28 (4.09%)
Ytd1263.64%
1y733.33%
6.51
day range
7.30
4.75
52 week range
12.30
Open6.75Prev Close6.72Low6.51High7.30Mkt Cap22.00M
Vol106.93KAvg Vol40.37KEPS-10.00P/EN/AForward P/E-1.16
Beta0.35Short Ratio2.03Inst. Own3.34%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0450-d Avg7.01200-d Avg7.211yr Est8.88

LGVN News

Stock Market Today: Dow Jones, S&P 500, Nasdaq 1000 Futures Advance as Scott Bessent Expands Sanctions on Iran—NTS, GRRR, REAX, ZM, LGVN in Focus (UPDATED)
benzinga.com
Stock Market Today: Dow Jones, S&P 500, Nasdaq 1000 Futures Advance as Scott Bessent Expands Sanctio

U.S. stock futures advanced on Tuesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, f

Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday
benzinga.com
Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday

US stock futures mixed as investors focus on earnings from Dick's Sporting Goods, Trade Desk, In

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 142.1% to $13.0 during Monday's

benzinga.com
Longeveron Announces 1-for-10 Reverse Stock Split, Expected To Become Effective August 26

Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy fo

Longeveron Announces 1-for-10 Reverse Stock Split
globenewswire.com
Longeveron Announces 1-for-10 Reverse Stock Split

MIAMI, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnol
benzinga.com
Longeveron Appoints Nirav Jhaveri CFO, Succeeding Marie Washburn

Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy fo

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
globenewswire.com
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business developm

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's aft

Longeveron Inc. (LGVN) Q2 2026 Earnings Call Transcript
seekingalpha.com
Longeveron Inc. (LGVN) Q2 2026 Earnings Call Transcript

Longeveron Inc. (LGVN) Q2 2026 Earnings Call Transcript
benzinga.com
Longeveron Q2 EPS $(0.19) Misses $(0.17) Estimate, Sales $287.000K Miss $334.000K Estimate

Longeveron (NASDAQ:LGVN) reported quarterly losses of $(0.19) per share which missed the analyst con

Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
globenewswire.com
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

On track for September 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laro

Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
globenewswire.com
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Heal

Longeveron selected as a Milestone 2 Awardee based on published clinical trial results which demonst

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
globenewswire.com
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 20

MIAMI, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage rege

Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
globenewswire.com
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors

MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) a clinical stage biotechnolo
benzinga.com
Longeveron Alzheimer’s Therapy Shows Brain Inflammation Benefits, Presents New Alzheimer’s Stem Cell

Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy fo

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer's Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer's Disease
globenewswire.com
Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer's Association International

Poster Presentation at the 2026 Alzheimer's Association International Conference (AAIC) entitled “La
benzinga.com
Longeveron Names Marie Washburn as Chief Financial Officer Effective On July 13; Lisa Locklear To St

Longeveron Inc. (NASDAQ:LGVN) a clinical stage biotechnology company developing cellular therapy for

Longeveron® Appoints Marie Washburn as Chief Financial Officer
globenewswire.com
Longeveron® Appoints Marie Washburn as Chief Financial Officer

Ms. Washburn has over 20 years of experience in leadership roles in the pharmaceutical and biotech s

Longeveron Inc. (LGVN) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com
Longeveron Inc. (LGVN) Shareholder/Analyst Call Prepared Remarks Transcript

Longeveron Inc. (LGVN) Shareholder/Analyst Call Prepared Remarks Transcript

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's
benzinga.com
Longeveron Announces Additional Analysis For Phase 2a Clinical Trial Of Mild Alzheimer's Disease Ste

Poster Presentation (Exhibit Hall) Date:Monday, July 13, 2026Time:7:30am – 4:15pm BSTSession:In-Pers

New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer's Disease Accepted for Poster Presentation at the 2026 Alzheimer's Association International Conference (AAIC)
globenewswire.com
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer's Disease A

MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnol
benzinga.com
Longeveron Granted Small Or Medium-Sized Enterprise Status By European Medicines Agency

According to the EMA, SME Designation has allowed for improved success rate for organizations seekin

Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
globenewswire.com
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (E

MIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnol
benzinga.com
Longeveron CFO Lisa Locklear Plans To Step Down, Effective July 10

https://www.sec.gov/ix?doc=/Archives/edgar/data/1721484/000121390026065788/ea0293758-8k_longeveron.h

Longeveron to Present at BIO International Convention 2026
globenewswire.com
Longeveron to Present at BIO International Convention 2026

Longeveron will present at BIO 2026. CEO, CFO & BD will host meetings to explore partnership opportu

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
globenewswire.com
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Appro

MIAMI, May 20, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnolo

Longeveron Inc. (LGVN) Q1 2026 Earnings Call Transcript
seekingalpha.com
Longeveron Inc. (LGVN) Q1 2026 Earnings Call Transcript

Longeveron Inc. (LGVN) Q1 2026 Earnings Call Transcript

Longeveron Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Longeveron Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Longeveron Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $398.000K Beat $314.667K Estimate

Longeveron (NASDAQ:LGVN) reported quarterly losses of $(0.19) per share which missed the analyst con

Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
globenewswire.com
Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update

On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromes

Earnings Scheduled For May 13, 2026
benzinga.com
Earnings Scheduled For May 13, 2026
benzinga.com
Longeveron Phase 2b HLHS Cell Therapy Trial Clears Final Safety Review; Top-Line Results Expected Au

Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLH

Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)
globenewswire.com
Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Com

Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLH

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
Longeveron Reports FDA Type C Meeting On Laromestrocel In HLHS; Agency Rejects RVEF Endpoint, Reques

The Company intends to submit to the FDA a Sponsor Statistical Analysis Plan (SAP) for ELPIS II with

Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
globenewswire.com
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Ph

MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerativ

Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026
globenewswire.com
Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026

MIAMI, May 05, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnolo
benzinga.com
HC Wainwright & Co. Maintains Buy on Longeveron, Lowers Price Target to $8

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Longeveron (NASDAQ:LGVN) with a Buy

Reviewing Longeveron (NASDAQ:LGVN) & Voyager Therapeutics (NASDAQ:VYGR)
defenseworld.net
Reviewing Longeveron (NASDAQ:LGVN) & Voyager Therapeutics (NASDAQ:VYGR)

Longeveron (NASDAQ: LGVN - Get Free Report) and Voyager Therapeutics (NASDAQ: VYGR - Get Free Report
benzinga.com
Longeveron Files Prospectus Related To Resale Of 30.865M Shares By Selling Stockholder

https://www.sec.gov/ix?doc=/Archives/edgar/data/1721484/000121390026042461/ea0285827-s1_longeveron.h
benzinga.com
Watching Longeveron; Zacks Small-Cap Research Gives Stock $10.45 Price Valuation

https://scr.zacks.com/files/News/2026/Zacks_SCR_Research_03182026_LGVN_Sorensen.pdf

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
Longeveron Q4 EPS $(0.22) Beats $(0.32) Estimate, Sales $365.000K Beat $148.000K Estimate

Longeveron (NASDAQ:LGVN) reported quarterly losses of $(0.22) per share which beat the analyst conse

Longeveron Braces For Q4 Results Following Recent Funding Boost
benzinga.com
Longeveron Braces For Q4 Results Following Recent Funding Boost

Longeveron Inc. shares are trading higher Tuesday as investors pivot their focus toward the company&

Earnings Scheduled For March 17, 2026
benzinga.com
Earnings Scheduled For March 17, 2026

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal
benzinga.com
Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal

Longeveron shares are trading sharply higher Tuesday afternoon following the announcement of a priva